State Street Corp Myriad Genetics Inc Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Myriad Genetics Inc stock. As of the latest transaction made, State Street Corp holds 4,809,949 shares of MYGN stock, worth $29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,809,949
Previous 5,268,790
8.71%
Holding current value
$29 Million
Previous $46.7 Million
45.35%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding MYGN
# of Institutions
233Shares Held
94.1MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$91.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$55.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$29.7 Million0.01% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$27.7 Million0.69% of portfolio
-
Morgan Stanley New York, NY4.55MShares$27.5 Million0.0% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $486M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...